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Although the environmentally harmful effects of widespread dichlorodiphenyltrichloroethane (DDT) use became
well-known following Rachel Carson’s Silent Spring (1962), its human health effects have more recently become
clearer. A ban on the use of DDT has been in place for over 30 years, but recently DDT has been used for malaria
control in areas such as Africa. Recent work shows that DDT has transgenerational effects in progeny and generations
never directly exposed to DDT. These effects have health implications for individuals who are not able to have any
voice in the decision to use the pesticide. The transgenerational effects of DDT are considered in light of some widely
accepted ethical principles. We argue that this reframes the decision to use DDT, requiring us to incorporate new
considerations, and new kinds of decision making, into the deliberative process that determines its ongoing use.
Ethical considerations for intergenerational environmental justice are presented that include concern and respect for
autonomy, nonmaleficence, and justice. Here, we offer a characterization of the kinds of ethical considerations that
must be taken into account in any satisfactory decisions to use DDT.
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A variety of environmental factors that include toxicants,
nutrition and stress have been shown to induce the epi-
genetic transgenerational inheritance of disease [1,2]
(Figure 1). Examples of such environmental compounds
include pesticides [3,4], fungicide vinclozolin [3], hydro-
carbons (jet fuel) [5], dioxin [6], and the plasticizers
phthalates and bisphenol A (BPA) [7]. Nutritional effects
such as high fat diets and caloric restriction can also
promote transgenerational abnormalities [8]. Epigenetic
transgenerational inheritance requires the germline
(sperm or egg) transmission of epigenetic information that
alters disease or phenotype, in the absence of direct envir-
onmental exposures [2]. Transgenerational phenomenon
have been demonstrated in humans [9], rodents [3], worms
[10], flies [11], and plants [12]. Therefore even though
you have never had a direct exposure, your ancestors’
environmental exposures may influence your disease
development (Figure 1). Environmentally induced epi-
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environmental policy.
A recent study examined the epigenetic transgenerational
actions of the most common historically used insecticide
DDT (dichlorodiphenyltoxichloroethane) [1]. Observations
demonstrate that DDT has the ability to induce the epige-
netic transgenerational inheritance of obesity, kidney, testis
and ovary disease [1]. Although the United States and most
developed countries have banned the use of DDT, recently
it has been used globally as an insecticide for control of
vectors for malaria. In 2001 the Stockholm Convention of
United Nations Environmental Program proposed the elim-
ination of 12 chemicals that induced DDT [13]. However,
due to the recent Gates Foundation Malaria Control Pro-
gram the use of DDT in Africa and other parts of the world
has increased since the Stockholm Convention [14]. The
World Health Organization (WHO) issued a position state-
ment in 2006 promoting the use of indoor residual spraying
with DDT for malaria vector control. The reported use
of DDT globally for disease vector control is over 5,000
metric tons per year with India being the largest con-
sumer [15]. Studies have indicated indoor spraying of
DDT causes high levels of human exposure [16]. The
direct DDT exposure toxic effects in humans includeed Central Ltd. This is an Open Access article distributed under the terms of
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Figure 1 Scheme for DDT induced epigenetic transgenerational inheritance of disease.
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[18], neurological disease [19], and cancer [20]. The ex-
posure DDT metabolite DDE (dichlorodiphenyldichlor-
oehtane) also promotes abnormal human health effects
such as childhood diabetes and obesity [21]. Therefore,
DDT exposure directly impacts human health [22].
DDT exposure also influences the health and promotes
birth defects in wildlife [23]. Despite DDT being a low-
cost anti-malaria tool, the adverse human health and
environmental effects (e.g. extremely long half-life) of
DDT use must be carefully weighed against the benefits
of malaria control [24].
The book ‘Silent Spring’ by Rachel Carson was published
over 50 years ago and revealed the hazards of DDT to hu-
man and wildlife health [25]. Currently the World Health
Organization (WHO) and the Gates Foundation promote
the use of DDT in developing countries in Africa for mal-
aria control. The current day potential hazards of DDT ex-
posures need to now be considered in light of the
transgenerational actions of DDT [1]. The various transge-
nerational diseases promoted by DDT include obesity, kid-
ney disease and ovarian disease [1]. The long-term health
and economic effects on survivors [26] and subsequent
generations [1] now needs to be considered with respect to
the number of lives saved from malaria. A more careful
risk-benefit consideration of the use of DDT is needed sinceother options exist with less toxic shorter half-life pesti-
cides. The primary objective of the following discussion is
to incorporate the concept of transgenerational inheritance.
Discussion
The unique aspect of the emerging work on the epigenetic
effects of DDT is that we now have good reason to believe
that DDT will negatively affect future generations. This
raises questions of intergenerational environmental justice.
Environmental justice concerns the distribution of
burdens and benefits on individuals via practices that
affect our environment. In her work, Kristin Shrader-
Frechette identifies the focus of environmental justice
as being on the disproportionate burdens faced by so-
cially disempowered individuals and groups (e.g., the
poor and racial and ethnic minorities) [27,28]. There
are now many accounts of these individuals and groups
suffering the ill effects of environmental degradation.
DDT use in the developing world looks set to be yet
another case in that sad history. Some evidence sug-
gests that the current generation is harmed by expo-
sure to DDT. The recent work cited above indicates
health hazards for descendants of those exposed now.
Thus, the harm will only fully emerge over the course
of a number of generations. This is why DDT use is
also an issue of intergenerational justice.
Table 1 Ethical considerations for intergenerational
environmental justice
1 Consent/Respect for Autonomy: Members of future generations cannot
consent to risks and harms imposed by earlier generations.
2 Nonmaleficence: Members of future generations are harmed, via
health deficits associated with epigenetics, due to exposure of
ancestors to DDT (and other toxicants).
3 Justice: Members of future generations bear a disproportionate
balance of risks and harms, whereas members of the current
generation, when DDT is being used, enjoy disproportionate benefits.
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examine how our practices and activities will impose
burdens (and benefits) on those who will inhabit the
world 50 or 100 or 500 years from now [29]. We now
have good reason to believe, based on the evidence dis-
cussed above, that the use of DDT will impose burdens
on individuals in the next two or four generations, at
least, while the current generation enjoys the benefits of
its use. As we discuss below, questions of intergenera-
tional justice differ from other kinds of decisions. All the
affected parties are not known in advance because some
do not yet exist. Who comes to exist in the future, and
what health deficits they might face, is determined by
decisions, both individual and policy-level, made today.
Of course, the question of what the present generation
owes future generations is greatly complicated by the
non-identity problem and related issues [30]. We will
directly address these complications in future work,
though here we hope to limit our claims so as to avoid
the most difficult questions raised by that problem.
We characterize the ethical issues in terms of environ-
mental injustice because those who might live in the fu-
ture are the ultimate socially disempowered group. They
can have no input into or control over environmental
conditions that will affect their well-being. They are vul-
nerable to harms and have no clear opportunity to benefit
from the current generation’s use of DDT.
The provisional case that current DDT use’s impacts
on future generations is an instance of intergenerational
environmental injustice can be developed in terms of
three moral concerns. First, the offspring of those ex-
posed to high levels of DDT today are harmed in that
the offspring’s health interests are set back by ancestral
exposure. The principle of nonmaleficence concisely ex-
presses the widely-held moral conviction that it is wrong
to harm another, other things being equal. Assuming that
any offspring of individuals exposed to DDT will be
harmed by the ancestral exposure, the principle of nonma-
leficence applies, even to future generations. Second, while
many individuals might consent to undergo risk or actual
harm, for some compensating benefit, the offspring can-
not consent prior to the onset of the mechanism of injury.
This violates respect for autonomy, which would otherwise
be expressed, partially, in the ability to make an informed
consent to assume risk or harm. Of course, those who do
not exist yet do not have any autonomy to respect. Thus,
they cannot consent to take on the epigenetic harm that
will affect whoever comes to exist. Finally, the principle of
justice calls for the distribution of benefits and burdens
(including harms) in some kind of principled manner.
DDT use affecting future generations through epigenetic
harm seems to be a good provisional example of an unfair
imposition of harm without corresponding benefit. At the
very least, justice would seem to require that anyone likelyto be harmed by action taken today be able to have a
“place at the table” in discussion of whether to use sub-
stances like DDT. The three principles discussed here are
elaborated and defended in Beauchamp & Childress [31]
(Table 1).
One objection might say that if DDT had not been used
in the current generation (F0), then members of a future
generation (F3) who are the progeny of F0 might not have
come to exist (Figure 1). Members of the F0 generation
might have died of malaria before having children. Thus,
the alleged cause of harm to the F3 generation, the use of
DDT in F0, might actually also be part of what enables F3
to come to exist. How might this affect the provisional
claim that current DDT use (in F0) is ethically suspect?
First, that the objection exists does not immediately justify
the status quo. The objection is based on quite a few con-
ditional claims. For example, if members of F3 never came
to exist, they would not be harmed by not existing [30].
The non-identity problem raises notorious complex ques-
tions of why it would be wrong to bring into existence a
person who suffers health deficits, but who would not
exist if not for the mechanism that also caused those defi-
cits. Here we lack the space to fully address this concern,
but in future work we hope to develop an agent-based ac-
count of wrong action that can be used to address the
counterintuitive implications of the non-identity problem.
Wasserman argues that an agent’s reasons for acting can
be the target of ethical evaluation [32]. Agents who act
from moral vice or the absence of virtue might be ethically
criticized even given the non-identity problem. We hope
to develop this agent-based approach for dealing with ac-
tions that have transgenerational implications. While it is
not clear to us that the current use of DDT is obviously
wrong, it now requires, we think, a more elaborate justifi-
cation given its epigenetic effects.
That deaths of members of F0 are avoidable, via malaria
prevention, does raise an ethical concern in itself (again,
the principle of nonmaleficence would be relevant here).
But if there are alternative ways to prevent malaria deaths
in F0, we should obviously consider them. A number of
organochlorine pesticides with shorter half-lives (i.e.
methoxychlor, aldrin, dieldrine and eldrin) have been
used and shown not to be as persistent environmental
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such as bifenthrin [34], chlorfenapyr [35], and pirimiphos
[36] have been shown to be effective as alternatives for
DDT consideration. Although the alternatives like me-
thoxychlor may promote transgenerational disease [37],
more recently developed pesticides such as nicotinoids
are also alternatives to consider [38,39]. Clearly factors
such as cost and half-life which would require more fre-
quent distribution are factors, this consideration would
have to be part of the decision making process [15].
However, as our understanding of the health deficits to
future generations due to the current generation’s use of
DDT become clearer, this can significantly shift the bal-
ance of burdens. The “true cost” of using the less expen-
sive and long half-life pesticide is shifted to members of
the F3 generation who experience that cost in terms of
health deficits and in the money needed, if possible, to
correct or ameliorate those health deficits. Their lives
and well-being cannot be discounted in the same way
that economists discount future commodities [40,41].
Thus, any future health care costs caused by actions
taken today need to be incorporated into a cost-benefit
assessment. We do not claim to have worked out that
decision making process, but we do argue that new con-
cerns about epigenetic harm and transgenerational in-
heritance should reframe that process. Policy makers
need to incorporate these considerations of transgenera-
tional justice into their deliberation.
Concern about the well-being of members of the F0
generation, as well as members of the F3 generation, appear
to call for some sort of trade-off or balancing of benefits
and burdens. While we do not have space here to fully con-
sider all the ramifications of this trade-off, we believe it is
important to recognize that the decision to use DDT in the
current generation has this implication. Very briefly, we
note that the F0 generation might benefit from DDT use by
the preservation of life and health (freedom from malaria)
in the current generation. The F0 generation might also ex-
perience some burdens associated with its exposure to
DDT [42]. And, F0 might experience harms if DDT is not
used. However, the F3 generation would not be harmed by
not using DDT regardless of whether not using DDT
harmed the F0 generation. In a scenario where members of
the F3 generation never come to exist because their great-
grandparents died prior to reproducing, there can be no
harm to those who do not yet, or never, come to exist.
Members of F3 would be harmed, again by appeal to the re-
cent epigenetic findings, if DDT is used. Finally, it strikes us
as important that a mechanism that might allow one to live
(DDT use) would also be a mechanism that causes one’s
health deficits. The ethics of reproducing is surely compli-
cated, but, again, it is not clear that ensuring F3’s existence
by means of inducing harm in those who come to exist is
an obviously right action.Conclusions
On this admittedly brief analysis of the trade-offs, it is cer-
tainly not clear that the F3 generation would benefit more
from current use of DDT than from not using it. If there
are alternatives for preventing malaria in the F0 gener-
ation that do not cause epigenetic harm, then the case for
using them would seem to be ethically superior to any
trade-off scenario involving continued use of DDT.
We draw two conclusions from this analysis. First, be-
cause recent empirical findings show that DDT is likely to
cause intergenerational harm, policies involving its use
should be re-considered to incorporate these new con-
cerns into the decision procedure to use DDT. We have
tried to highlight some of those new concerns in ethical
terms (Table 1). Second, the provisional case against DDT
use is fairly strong. This further strengthens the call for al-
ternative means of preventing malaria and for discontinu-
ing DDT use. But even if we lack a conclusive argument
against current DDT use, we believe we have done enough
to shift the burden of proof back to the advocates of its
use. Perhaps our most important conclusion is that an un-
reflective continuation of the status quo with respect to
DDT use is unacceptable. It needs to be defended against
concerns about the intergenerational effects it will cause.
Abbreviations
BPA: Bisphenol A; DDE: Dichlorodiphenyldichloroehtane;
DDT: Dichlorodiphenyltrichloroethane; F0: Generation pregnant female;
F1: Generation fetus that becomes the offspring or children; F2: Generation
(grandchildren); F3: Generation (great-grandchildren); WHO: The World
Health Organization.
Competing interests
The authors declare no competing financial interests.
Authors’ contributions
MKS conceived the study. MKS and WPK designed and wrote the study. Both
authors edited and approved the manuscript.
Acknowledgements
We thank Ms. Heather Johnson for assistance in preparation of the
manuscript and Dr. Eric Nilsson for critically reviewing the manuscript. The
research was supported by NIH grants to MKS.
Author details
1Center for Reproductive Biology, School of Politics, Philosophy, and Public
Affairs, Washington State University, Pullman, WA, USA. 2Center for
Reproductive Biology, School of Biological Sciences, Washington State
University, Pullman, WA, USA.
Received: 20 May 2014 Accepted: 29 July 2014
Published: 2 August 2014
References
1. Skinner MK, Manikkam M, Tracey R, Nilsson E, Haque MM, Guerrero-Bosagna
C: Ancestral DDT Exposures Promote Epigenetic Transgenerational
Inheritance of Obesity. BMC Med 2013, 11:228.
2. Skinner MK, Manikkam M, Guerrero-Bosagna C: Epigenetic transgenerational
actions of environmental factors in disease etiology. Trends Endocrinol Metab
2010, 21:214–222.
3. Anway MD, Cupp AS, Uzumcu M, Skinner MK: Epigenetic
transgenerational actions of endocrine disruptors and male fertility.
Science 2005, 308:1466–1469.
Kabasenche and Skinner Environmental Health 2014, 13:62 Page 5 of 5
http://www.ehjournal.net/content/13/1/624. Manikkam M, Guerrero-Bosagna C, Tracey R, Haque MM, Skinner MK:
Transgenerational actions of environmental compounds on
reproductive disease and epigenetic biomarkers of ancestral
exposures. PLoS One 2012, 7:e31901.
5. Tracey R, Manikkam M, Guerrero-Bosagna C, Skinner M: Hydrocarbon
(Jet Fuel JP-8) induces epigenetic transgenerational inheritance of
adult-onset disease and sperm epimutations. Reprod Toxicol 2013,
36:104–116.
6. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner MK: Dioxin (TCDD)
induces epigenetic transgenerational inheritance of adult onset disease
and sperm epimutations. PLoS One 2012, 7:e46249.
7. Manikkam M, Tracey R, Guerrero-Bosagna C, Skinner M: Plastics Derived
Endocrine Disruptors (BPA, DEHP and DBP) induce epigenetic
transgenerational inheritance of adult-onset disease and sperm
epimutations. PLoS One 2013, 8:e55387.
8. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S: Methyl donor
supplementation prevents transgenerational amplification of obesity.
Int J Obes (Lond) 2008, 32:1373–1379.
9. Pembrey ME: Male-line transgenerational responses in humans. Hum Fertil
(Camb) 2010, 13:268–271.
10. Greer EL, Maures TJ, Ucar D, Hauswirth AG, Mancini E, Lim JP, Benayoun BA,
Shi Y, Brunet A: Transgenerational epigenetic inheritance of longevity in
Caenorhabditis elegans. Nature 2011, 479:365–371.
11. Ruden DM, Lu X: Hsp90 affecting chromatin remodeling might explain
transgenerational epigenetic inheritance in Drosophila. Curr Genomics
2008, 9:500–508.
12. Hauser MT, Aufsatz W, Jonak C, Luschnig C: Transgenerational epigenetic
inheritance in plants. Biochim Biophys Acta 2011, 1809:459–468.
13. Davies K: Strategies for eliminating and reducing persistent
bioaccumulative toxic substances: common approaches, emerging
trends, and level of success. J Environ Health 2006, 69:9–15. 36, 38.
14. Enayati A, Hemingway J: Malaria management: past, present, and future.
Annu Rev Entomol 2010, 55:569–591.
15. van den Berg H: Global status of DDT and its alternatives for use in vector
control to prevent disease. Environ Health Perspect 2009, 117:1656–1663.
16. Aneck-Hahn NH, Schulenburg GW, Bornman MS, Farias P, De Jager C:
Impaired semen quality associated with environmental DDT exposure in
young men living in a malaria area in the Limpopo Province. South Africa
J Androl 2007, 28:423–434.
17. Longnecker MP, Klebanoff MA, Zhou H, Brock JW: Association between
maternal serum concentration of the DDT metabolite DDE and preterm
and small-for-gestational-age babies at birth. Lancet 2001, 358:110–114.
18. Hauser R, Singh NP, Chen Z, Pothier L, Altshul L: Lack of an association
between environmental exposure to polychlorinated biphenyls and p,
p’-DDE and DNA damage in human sperm measured using the neutral
comet assay. Hum Reprod 2003, 18:2525–2533.
19. ATSDR: Agency for Toxic Substances and Diseases Registry (ATSDR)/US Public
Health Service, Toxicological Profile for 4,4’-DDT, 4,4’-DDE, 4, 4’-DDD (Update).
Atlanta, GA: ATSDR; 1994.
20. Jaga K, Brosius D: Pesticide exposure: human cancers on the horizon. Rev
Environ Health 1999, 14:39–50.
21. Valvi D, Mendez MA, Martinez D, Grimalt JO, Torrent M, Sunyer J, Vrijheid M:
Prenatal concentrations of polychlorinated biphenyls, DDE, and DDT and
overweight in children: a prospective birth cohort study. Environ Health
Perspect 2012, 120:451–457.
22. Guimaraes RM, Asmus CI, Meyer A: DDT reintroduction for malaria control:
the cost-benefit debate for public health. Cad Saude Publica 2007,
23:2835–2844.
23. Hamlin HJ, Guillette LJ Jr: Birth defects in wildlife: the role of
environmental contaminants as inducers of reproductive and
developmental dysfunction. Syst Biol Reprod Med 2010, 56:113–121.
24. Sadasivaiah S, Tozan Y, Breman JG: Dichlorodiphenyltrichloroethane (DDT)
for indoor residual spraying in Africa: how can it be used for malaria
control? Am J Trop Med Hyg 2007, 77:249–263.
25. Carson R: Silent Spring. Greenburg: Houghton Mifflin; 1963.
26. Rogan WJ, Chen A: Health risks and benefits of bis(4-chlorophenyl)-1,1,1-
trichloroethane (DDT). Lancet 2005, 366:763–773.
27. Shrader-Frechette K: Environmental Justice: Creating Equality. Oxford UP:
Reclaiming Democracy New York; 2002.
28. Shrader-Frechette K: Taking Action, Saving Lives: Our Duties to Protect
Environmental and Public Health. New York: Oxford UP; 2007.29. De Shalit A: Why Posterity Matters: Environmental Policies and Future
Generations. New York: Routledge; 1995.
30. Parfit D: Reasons and Persons. New York: Oxford UP; 1984.
31. Beauchamp TL, Childress JF: Principles of Biomedical Ethics. 7th edition.
New York: Oxford UP; 2013.
32. Wasserman D: The nonidentity problem, disability, and the role morality
of prospective parents. Ethics 2005, 116:132–152.
33. Sarkar SK, Bhattacharya BD, Bhattacharya A, Chatterjee M, Alam A,
Satpathy KK, Jonathan MP: Occurrence, distribution and possible sources
of organochlorine pesticide residues in tropical coastal environment of
India: an overview. Environ Int 2008, 34:1062–1071.
34. Batra CP, Raghavendra K, Adak T, Singh OP, Singh SP, Mittal PK, Malhotra
MS, Sharma RS, Subbarao SK: Evaluation of bifenthrin treated mosquito
nets against anopheline and culicine mosquitoes. Indian J Med Res 2005,
121:55–62.
35. Raghavendra K, Barik TK, Sharma P, Bhatt RM, Srivastava HC, Sreehari U,
Dash AP: Chlorfenapyr: a new insecticide with novel mode of action can
control pyrethroid resistant malaria vectors. Malar J 2011, 10:16.
36. Rowland M, Boko P, Odjo A, Asidi A, Akogbeto M, N’Guessan R: A new
long-lasting indoor residual formulation of the organophosphate
insecticide pirimiphos methyl for prolonged control of pyrethroid-
resistant mosquitoes: an experimental hut trial in Benin. PLoS One 2013,
8:e69516.
37. Manikkam MMHM, Guerrero-Bosagna C, Nilsson E, Skinner M: Pesticide
methoxychlor promotes the epigenetic transgenerational inheritance
of adult onset disease through the female germline. PLoS One 2014,
9:e10209.
38. Tonder JE, Olesen PH: Agonists at the alpha4beta2 nicotinic acetylcholine
receptors: structure-activity relationships and molecular modelling.
Curr Med Chem 2001, 8:651–674.
39. Tomizawa M, Casida JE: Unique neonicotinoid binding conformations
conferring selective receptor interactions. J Agric Food Chem 2011,
59:2825–2828.
40. Broome J: Weighing Lives. New York: Oxford University Press; 2004.
41. Broome J: Climate Matters: Ethics in a Warming World. New York: W.W.
Norton & Company; 2012.
42. Unprecedented Use of DDT Concerns Experts. [www.sciencedaily.com/
releases/2009/05/090504122058.htm]
doi:10.1186/1476-069X-13-62
Cite this article as: Kabasenche and Skinner: DDT, epigenetic harm, and
transgenerational environmental justice. Environmental Health 2014 13:62.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
